Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-072481

Director acquired 6,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Coleman Mark · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-23 Exercise or conversion : show line 1 in the form +6,250 $4.95 $30,938 72,140 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-23 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −6,250 7,721 D
Loading xslF345X05/ownership.xml…